Literature DB >> 21137622

Diagnosis and treatment of Acanthosis nigricans.

Shailendra Kapoor1.   

Abstract

Acanthosis nigricans is a dermatologic condition commonly seen in diabetics and obese individuals. Histologically, it is characterized by the proliferation of epidermal keratinocytes and fibroblasts. Clinically, the lesions appear as dark-brown thickened plaques. The neck and the axillas are the most commonly affected sites. Treatment involves management of the underlying disorder. Topical tretinoin and calcipotriol have also been used with some limited success. Other treatment options include laser and surgical excision.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21137622

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  6 in total

1.  Psychological and social factors in undergoing reconstructive surgery among individuals with craniofacial conditions: an exploratory study.

Authors:  Heather Bemmels; Barbara Biesecker; Johanna L Schmidt; Alyson Krokosky; Rick Guidotti; Erica J Sutton
Journal:  Cleft Palate Craniofac J       Date:  2012-02-08

Review 2.  Insulin resistance and skin diseases.

Authors:  Maddalena Napolitano; Matteo Megna; Giuseppe Monfrecola
Journal:  ScientificWorldJournal       Date:  2015-04-21

3.  Oral malignant acanthosis nigricans associated with endometrial adenocarcinoma.

Authors:  Han-Wen Chu; Jing-Min Li; Guan-Fu Chen; Jing-Yuan Ma
Journal:  Int J Oral Sci       Date:  2014-01-10       Impact factor: 6.344

Review 4.  Acanthosis nigricans in obese adolescents: prevalence, impact, and management challenges.

Authors:  Hak Yung Ng
Journal:  Adolesc Health Med Ther       Date:  2016-12-16

Review 5.  An approach to acanthosis nigricans.

Authors:  Meghana Madhukar Phiske
Journal:  Indian Dermatol Online J       Date:  2014-07

6.  Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans.

Authors:  Yi Zhang; Cuiling Zhu; Xin Wen; Xingchun Wang; Liang Li; Sharvan Rampersad; Liesheng Lu; Donglei Zhou; Chunhua Qian; Ran Cui; Manna Zhang; Peng Yang; Shen Qu; Le Bu
Journal:  Lipids Health Dis       Date:  2017-11-07       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.